Literature DB >> 24019452

Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".

Jonathan P Piccini1, Susanna R Stevens, Yuchiao Chang, Daniel E Singer, Yuliya Lokhnygina, Alan S Go, Manesh R Patel, Kenneth W Mahaffey, Jonathan L Halperin, Günter Breithardt, Graeme J Hankey, Werner Hacke, Richard C Becker, Christopher C Nessel, Keith A A Fox, Robert M Califf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24019452     DOI： 10.1161/CIRCULATIONAHA.113.004013

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke.

Authors:  Juan F Viles-Gonzalez; Vivek Y Reddy; Jan Petru; Tomas Mraz; Zuzana Grossova; Stepan Kralovec; Petr Neuzil
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.

Authors:  Christina L Fanola; Deirdre Mooney; Andrew J Cowan; Darae Ko; Emily K Sisson; Lori E Henault; Yorghos Tripodis; Elaine M Hylek
Journal:  Am Heart J       Date:  2016-11-04       Impact factor: 4.749

Review 3.  Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

Authors:  Miho Kimachi; Toshi A Furukawa; Kimihiko Kimachi; Yoshihito Goto; Shingo Fukuma; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06

4.  The European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation - A Brief Summary.

Authors:  Paulus Kirchhof
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.